Aciphex Sales Data
Last updated: February 2014 (updated quarterly).
The following data shows Aciphex U.S. retail sales in Q4 2013 compared to previous quarters.
| Date Range | Sales Rank | Sales ($000) | Units (000) | ||
|---|---|---|---|---|---|
| Q3 2013 | 94 ( 11) |
$183,098 | -6.83% | 581 | -0.34% |
| Q2 2013 | 83 (5) |
$196,514 | -6.17% | 583 | -10.58% |
| Q1 2013 | 78 (5) |
$209,443 | -1.84% | 652 | -10.56% |
| Q4 2012 | 73 | $213,378 | -1.07% | 729 | -1.88% |
| Q3 2012 | 73 ( 6) |
$215,681 | 10.07% | 743 | -2.37% |
| Q2 2012 | 79 (1) |
$195,946 | -3.52% | 761 | -3.91% |
| Q1 2012 | 80 (3) |
$203,097 | -1.77% | 792 | -4.81% |
| Q4 2011 | 77 (2) |
$206,760 | -1.37% | 832 | -1.54% |
| Q3 2011 | 75 (3) |
$209,632 | -6.32% | 845 | -10.77% |
| Q2 2011 | 72 (1) |
$223,768 | -4.54% | 947 | -4.63% |
| Q1 2011 | 71 | $234,407 | n/a | 993 | n/a |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
